Ascendiant Capital Initiates Coverage On NRX Pharmaceuticals With Buy Rating, Announces Price Target of $4
Ascendiant Capital Initiates Coverage On NRX Pharmaceuticals With Buy Rating, Announces Price Target of $4
Ascendiant Capital以買入評級開始對NRX Pharmicals進行報道，宣佈目標股價爲4美元
Ascendiant Capital analyst Edward Woo initiates coverage on NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy rating and announces Price Target of $4.
Ascendiant Capital分析師Edward Woo以買入評級開始對NRX Pharmicals（納斯達克股票代碼：NRXP）進行報道，並宣佈目標股價爲4美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。